The University of Chicago Header Logo

TTF-1 positive posterior pituitary tumor: Limitations of current treatment and potential new hope in BRAF V600E mutation variants.

TTF-1 positive posterior pituitary tumor: Limitations of current treatment and potential new hope in BRAF V600E mutation variants. Clin Neurol Neurosurg. 2020 Sep; 196:106059.

View in: PubMed